Avedro, Inc. Options Rights to Intellectual Property

2/29/2012 7:22:03 AM

WALTHAM, Mass.--(BUSINESS WIRE)--Avedro, Inc. announced today that the Company has entered into an exclusive Option Agreement with the Cleveland Clinic for the right to negotiate a license for 3 specific Intellectual Property (IP) assets to enhance the Company’s existing portfolio of cross-linking therapies and diagnostics. If Avedro licenses this technology it intends to utilize it in the development of the company's products.

Read at BioSpace.com

Read Article at

Related Companies

News Categories

• BioSpace.com

• Avedro, Inc.

• Biotech/Pharma - Alliances

• Biotech/Pharma - Regulatory

• Diagnostics

• Medical Devices

• Medical Dev. & Diag. - Alliances

• Medical Dev. & Diag. - Regulatory